Columbia study underscores complexities of deadly neurodegenerative disease; offers promising strategies to target disease’s underlying genetic mechanisms.
Do the experiences of your father leave a mark on your genes? Can trauma be passed down from generation to generation?
Columbia-led team harnesses two powerful technologies to identify promising targets for diagnosing and treating neurodegenerative diseases.
Mentored by Nobel laureate Eric Kandel, two young scientists team up and discover they have a lot in common.
Columbia-led study offers new insight into organization of brain’s listening center; provides roadmap for development of hearing-aid technologies inspired by the brain
Academy recognizes Dr. Costa’s outstanding contributions to the brain science of movement and learning that has yielded insights into Parkinson’s disease, autism and obsessive-compulsive disorder.
Findings reveal potential new strategy for treating people diagnosed with schizophrenia.
New SCAPE 2.0 system can serve as a critical tool to advance science and medicine.
As part of Chan Zuckerberg Initiative's newly formed Seed Networks for the Human Cell Atlas, Columbia team will work to advance broad-scale efforts to treat spinal cord injury and disease.
Columbia’s Zuckerman Institute hosts gathering of leading neuroscientists from across the country
